Tobidex is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
Warnings and cautions when taking drugs
Tight, dry container below 30°C; protect from light, heat, moisture
Dosage and Administration
One or two drops instilled into the conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to one or two drops every two hours. Dosage should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.